CA2368242A1 - Combination therapy for treating glaucoma - Google Patents
Combination therapy for treating glaucoma Download PDFInfo
- Publication number
- CA2368242A1 CA2368242A1 CA002368242A CA2368242A CA2368242A1 CA 2368242 A1 CA2368242 A1 CA 2368242A1 CA 002368242 A CA002368242 A CA 002368242A CA 2368242 A CA2368242 A CA 2368242A CA 2368242 A1 CA2368242 A1 CA 2368242A1
- Authority
- CA
- Canada
- Prior art keywords
- iop
- lowering agent
- alkyl
- glutamate
- glutamate antagonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US1999/005423 WO2000054810A1 (en) | 1999-03-12 | 1999-03-12 | Combination therapy for treating glaucoma |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2368242A1 true CA2368242A1 (en) | 2000-09-21 |
Family
ID=22272341
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002368242A Abandoned CA2368242A1 (en) | 1999-03-12 | 1999-03-12 | Combination therapy for treating glaucoma |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1169061A1 (zh) |
AU (1) | AU3082999A (zh) |
CA (1) | CA2368242A1 (zh) |
HK (1) | HK1040184A1 (zh) |
WO (1) | WO2000054810A1 (zh) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
MXPA01008955A (es) | 1999-03-05 | 2002-04-24 | Procter & Gamble | Analogos de prostaglandinas selectivas de fp no saturadas de c16. |
US20020172693A1 (en) | 2000-03-31 | 2002-11-21 | Delong Michell Anthony | Compositions and methods for treating hair loss using non-naturally occurring prostaglandins |
US20020013294A1 (en) | 2000-03-31 | 2002-01-31 | Delong Mitchell Anthony | Cosmetic and pharmaceutical compositions and methods using 2-decarboxy-2-phosphinico derivatives |
US7186745B2 (en) | 2001-03-06 | 2007-03-06 | Astrazeneca Ab | Indolone derivatives having vascular damaging activity |
TWI298257B (en) | 2001-05-31 | 2008-07-01 | Allergan Inc | Hypotensive lipid and timolol compositions and methods of using same |
US8758733B2 (en) | 2002-02-04 | 2014-06-24 | Allergan, Inc. | Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists |
US7351404B2 (en) | 2002-02-04 | 2008-04-01 | Allergan, Inc. | Method of enhancing hair growth |
US9216183B2 (en) | 2002-02-04 | 2015-12-22 | Allergan, Inc. | Topical treatment for chemotherapy induced eyelash loss or hypotrichosis using prostamide F2 alpha agonists |
US20050031652A1 (en) * | 2003-02-25 | 2005-02-10 | Allergan, Inc. | Compositions and methods comprising memantine and polyanionic polymers |
JP2008507557A (ja) * | 2004-07-22 | 2008-03-13 | ヴァンダ ファーマシューティカルズ インコーポレイテッド | 眼疾患の治療法 |
JP2008507588A (ja) * | 2004-07-26 | 2008-03-13 | アラーガン、インコーポレイテッド | 眼の病態を処置する方法 |
EP1799264A2 (en) * | 2004-10-08 | 2007-06-27 | Neuromolecular Pharmaceuticals Inc | Methods and compositions for treating migraine pain |
US20070167527A1 (en) * | 2006-01-13 | 2007-07-19 | Burke James A | Memantine for the normalization of visual acuity deficits |
KR20170095402A (ko) | 2009-11-09 | 2017-08-22 | 알러간, 인코포레이티드 | 모발 성장을 촉진하기 위한 조성물 및 방법 |
US9149484B2 (en) | 2009-11-09 | 2015-10-06 | Allergan, Inc. | Compositions and methods for stimulating hair growth |
US9061034B2 (en) | 2010-07-29 | 2015-06-23 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
CA2807081C (en) | 2010-07-29 | 2018-09-18 | Allergan, Inc. | Preservative free bimatoprost and timolol solutions |
US8859616B2 (en) | 2011-01-21 | 2014-10-14 | Allergan, Inc. | Compounds and methods for enhancing hair growth |
JP2021531327A (ja) * | 2018-06-19 | 2021-11-18 | セラ セラピューティクス エルエルシー | 眼圧降下剤、cnp化合物、nrp−b化合物、tie−2アゴニスト、または神経栄養剤を含む、緑内障または高眼圧症を治療するための徐放性薬剤送達系 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1057486A1 (en) * | 1995-11-17 | 2000-12-06 | Alcon Laboratories, Inc. | Use of drug combination for treating Glaucoma |
-
1999
- 1999-03-12 WO PCT/US1999/005423 patent/WO2000054810A1/en active Application Filing
- 1999-03-12 AU AU30829/99A patent/AU3082999A/en not_active Abandoned
- 1999-03-12 CA CA002368242A patent/CA2368242A1/en not_active Abandoned
- 1999-03-12 EP EP99912458A patent/EP1169061A1/en not_active Withdrawn
-
2002
- 2002-02-19 HK HK02101195.9A patent/HK1040184A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
WO2000054810A1 (en) | 2000-09-21 |
HK1040184A1 (zh) | 2002-05-31 |
AU3082999A (en) | 2000-10-04 |
EP1169061A1 (en) | 2002-01-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6441047B2 (en) | Combination therapy for treating glaucoma | |
CA2368242A1 (en) | Combination therapy for treating glaucoma | |
KR100452715B1 (ko) | 녹내장및안구국소빈혈을치료하기위한특정이소퀴놀린술포닐화합물의용도 | |
JP2007217437A (ja) | カリウムチャンネル遮断剤の投与により、哺乳動物の眼圧を降下する方法 | |
AU704938B2 (en) | Combination therapy for treating glaucoma | |
US6264935B1 (en) | Ophthalmic composition containing a carbonic anhydrase inhibitor and xanthan gum | |
US6545045B1 (en) | Prostaglandin E agonists for treatment of glaucoma | |
EP0672417A1 (en) | Reduction of elevated intraocular pressure | |
EP1267847B1 (en) | 5ht 2 agonists for controlling iop and treating glaucoma | |
US6200990B1 (en) | Neuroprotective agents having antioxidant and NMDA antagonist activity | |
US5578638A (en) | Treatment of glaucoma and ocular hypertension with β3 -adrenergic agonists | |
EP1647274A1 (en) | Remedy for pruritus comprising piperidine derivative as the active ingredient | |
EP3730137B1 (en) | Therapeutic agent for glaucoma comprising an fp agonist and timolol | |
AU2004214563A1 (en) | Combination therapy for treating glaucoma | |
US5308849A (en) | Method of reducing elevated intraocular pressure | |
AU2001217709B2 (en) | Combination therapy for lowering and controlling intraocular pressure | |
EP0728480A1 (en) | Use of ifenprodil for treatment of elevated intraocular pressure | |
US6927233B1 (en) | 5ht2 agonists for controlling IOP and treating glaucoma | |
AU2001217709A1 (en) | Combination therapy for lowering and controlling intraocular pressure | |
EP0277814B1 (en) | Anti-glaucoma use of trifluoromethanesulfonamide | |
AU716577B2 (en) | Use of polyamine antagonists for the treatment of glaucoma | |
EP0607697A2 (en) | DILAZEP for reduction of elevated intraocular pressure | |
US20040058976A1 (en) | Ophthalmic compositions for treating ocular hypertension |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |